NewAmsterdam Pharma Warrant
NAMSW
NAMSW
10 hedge funds and large institutions have $10.4M invested in NewAmsterdam Pharma Warrant in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
10
Holding in Top 10
–
Calls
$600K
Puts
–
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FLSM
1
Frazier Life Sciences Management
Palo Alto,
California
| $4M |
|
|||
|
RCM
2
RA Capital Management
Boston,
Massachusetts
| $2.67M |
|
|||
|
AAA
3
Affinity Asset Advisors
New York
| $1.96M |
|
|||
|
BCLSI
4
Bain Capital Life Sciences Investors
Boston,
Massachusetts
| $800K |
|
|||
|
DM
5
Deerfield Management
New York
| $742K |
|
|||
|
LCM
6
Laurion Capital Management
New York
| $133K |
|
|||
|
VI
7
Vestcor Inc
Fredericton,
New Brunswick, Canada
| $77K |
|
|||
8
CIBC Private Wealth Group
Atlanta,
Georgia
| $24.2K |
|
|||
|
WAM
9
Wolverine Asset Management
Chicago,
Illinois
| $16.7K |
|
|||
10
UBS Group
Zurich,
Switzerland
| $7.94K |
|